Study on Escherichia coli O-157-induced renal damage
大肠杆菌O-157所致肾损伤的研究
基本信息
- 批准号:11672273
- 负责人:
- 金额:$ 2.3万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Lipopolysaccharide (LPS) and verotoxin-2 (VT2) are involved in the Escherichia coli O-157-induced renal damage. However, pathophysiologic profiles are not fully evaluated after an injection of each agent. This study was undertaken to address this issue.1. Chronotoxicity of LPS in ratsLPS (5 mg/kg) was injected intravenously to Wistar rats at 9:00 or 21:00, and organ damages were evaluated. The degree of organ damages in the 21:00 trial were significantly greater than those in the 9:00 trial. The elevation in serum interleukin-6 (IL-6), an inflammatory cytokine, was greater and its synthesis in organs was more enhanced in the 21:00 trial. These data indicate that the toxicity of LPS depends on its dosing time, probably through the time-dependent difference in the IL-6 response.2. Preventive effect of anti-neutrophil antibody against the VT_2-induced organ damage in mice.VT_2 (100 ng) was injected intraperitoneally to C57BL/6 mice with and without the co-administration of anti-neutrophil mouse antibody at 0 and 24 hours following VT_2. After the injection of VT_2 alone, plasma neutrophil remarkably elevated and all animals died within 5 days after the VT_2 injection. Death rate was significantly reduced in mice with the anti-neutrophil antibody. These data suggest that neutrophil plays some role in the VT_2-induced organ damage.
大肠杆菌O-157致肾损害与脂多糖(LPS)和verotoxin-2(VT-2)有关。然而,每种药物注射后的病理生理学特征并未得到充分评价。本研究就是为了解决这一问题。LPS对大鼠的时间毒性于9:00或21:00给Wistar大鼠静脉注射LPS(5 mg/kg),观察其对大鼠脏器的损伤作用。21:00试验的器官损害程度明显大于9:00试验。在21:00试验中,血清白细胞介素-6(IL-6)(一种炎性细胞因子)的升高更大,其在器官中的合成也更增强。这些数据表明LPS的毒性取决于其给药时间,可能是通过IL-6反应的时间依赖性差异.抗中性粒细胞抗体对维生素T_2诱导的小鼠器官损伤的预防作用在给予维生素T_2(100 ng)后的0和24 h,给C57 BL/6小鼠腹腔注射维生素T_2(100 ng),同时给予抗中性粒细胞抗体和不给予抗中性粒细胞抗体。单独注射VT_2后,血浆中性粒细胞明显升高,所有动物均于注射后5天内死亡。在具有抗中性粒细胞抗体的小鼠中,死亡率显著降低。提示中性粒细胞在VT_2引起的器官损害中起一定作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJIMURA Akio其他文献
FUJIMURA Akio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJIMURA Akio', 18)}}的其他基金
Development of safety prediction biomarker for drug eluting coronary stent therapy
药物洗脱冠状动脉支架治疗安全预测生物标志物的开发
- 批准号:
17K19688 - 财政年份:2017
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Basic and clinical research aimed at elucidation of the pathological mechanism of aortic dissection and development of therapeutic methods
旨在阐明主动脉夹层病理机制和开发治疗方法的基础和临床研究
- 批准号:
16H05224 - 财政年份:2016
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of the method for reducing the adverse effect of arsenic trioxide
减少三氧化二砷不良影响的方法的研制
- 批准号:
22590504 - 财政年份:2010
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of bio-artificial kidney
生物人工肾的研制
- 批准号:
16591270 - 财政年份:2004
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preventive effect of an enkephalinase inhibitor on drug-induced nephrotoxicity.
脑啡肽酶抑制剂对药物引起的肾毒性的预防作用。
- 批准号:
05671902 - 财政年份:1993
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Use of bacteriophages for control of Salmonella and verotoxin-producing Escherichia coli in food supply systems
使用噬菌体控制食品供应系统中的沙门氏菌和产维罗毒素大肠杆菌
- 批准号:
489582-2016 - 财政年份:2019
- 资助金额:
$ 2.3万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Use of bacteriophages for control of Salmonella and verotoxin-producing Escherichia coli in food supply systems
使用噬菌体控制食品供应系统中的沙门氏菌和产维罗毒素大肠杆菌
- 批准号:
489582-2016 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Isolation, Effectiveness and Genome Analysis of Novel Verotoxin-producing Escherichia coli Bacteriophages
新型产维罗毒素大肠杆菌噬菌体的分离、有效性和基因组分析
- 批准号:
528717-2018 - 财政年份:2018
- 资助金额:
$ 2.3万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Use of bacteriophages for control of Salmonella and verotoxin-producing Escherichia coli in food supply systems
使用噬菌体控制食品供应系统中的沙门氏菌和产维罗毒素大肠杆菌
- 批准号:
489582-2016 - 财政年份:2017
- 资助金额:
$ 2.3万 - 项目类别:
Postgraduate Scholarships - Doctoral
Use of bacteriophages for control of Salmonella and verotoxin-producing Escherichia coli in food supply systems
使用噬菌体控制食品供应系统中的沙门氏菌和产维罗毒素大肠杆菌
- 批准号:
489582-2016 - 财政年份:2016
- 资助金额:
$ 2.3万 - 项目类别:
Postgraduate Scholarships - Doctoral
Quality control system that monitors ribosomes damaged by verotoxin
监测被维罗毒素损坏的核糖体的质量控制系统
- 批准号:
24657117 - 财政年份:2012
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Investigation on neutralizing efficacy against verotoxin and resistance to protease of bovine immune colostral antibody in mice and beagle dogs
牛免疫初抗体对小鼠和比格犬的维罗毒素中和及蛋白酶抗性研究
- 批准号:
20580315 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Preparation of the glycol-arrays for aiming at the ordered and well-defined accumulation and the analyses of the interaction to proteins
制备乙二醇阵列以实现有序且明确的积累并分析与蛋白质的相互作用
- 批准号:
20550150 - 财政年份:2008
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of a dsDNA imprinted polymer to detection for bacterial toxin
双链DNA印迹聚合物在细菌毒素检测中的应用
- 批准号:
18350080 - 财政年份:2006
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic Research for development of new drug against Shiga-toxin producing E.Coli infection
抗产志贺毒素大肠杆菌感染新药开发的基础研究
- 批准号:
17390038 - 财政年份:2005
- 资助金额:
$ 2.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)